| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |